{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T21:14:09Z","timestamp":1787606049787,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T00:00:00Z","timestamp":1556496000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00535-019-01587-5","type":"journal-article","created":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T11:03:07Z","timestamp":1556535787000},"page":"963-971","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Is the new potent acid-inhibitory drug vonoprazan effective for healing idiopathic peptic ulcers? A multicenter observational study in Akita Prefecture, Japan"],"prefix":"10.1007","volume":"54","author":[{"given":"Kae","family":"Sugawara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeto","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Horikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuya","family":"Mimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyotoshi","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusei","family":"Fujimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Onochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,29]]},"reference":[{"key":"1587_CR1","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1111\/j.1572-0241.2002.07068.x","volume":"97","author":"C Quan","year":"2002","unstructured":"Quan C, Talley NJ. Management of peptic ulcer disease not related to Helicobacter pylori or NSAIDs. Am J Gastroenterol. 2002;97:2950\u201361.","journal-title":"Am J Gastroenterol"},{"key":"1587_CR2","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3748\/wjg.v20.i3.706","volume":"20","author":"K Iijima","year":"2014","unstructured":"Iijima K, Kanno T, Koike T, et al. Helicobacter pylori-negative, non-steroidal anti-inflammatory drug: negative idiopathic ulcers in Asia. World J Gastroenterol. 2014;20:706\u201313.","journal-title":"World J Gastroenterol"},{"key":"1587_CR3","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1053\/j.gastro.2005.03.026","volume":"128","author":"LC Hung","year":"2005","unstructured":"Hung LC, Ching JY, Sung JJ, et al. Long-term outcome of Helicobacter pylori-negative idiopathic bleeding ulcers: a prospective cohort study. Gastroenterology. 2005;128:1845\u201350.","journal-title":"Gastroenterology"},{"key":"1587_CR4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00535-012-0681-1","volume":"48","author":"T Kanno","year":"2013","unstructured":"Kanno T, Iijima K, Abe Y, et al. Peptic ulcers after the Great East Japan earthquake and tsunami: possible existence of psychosocial stress ulcers in humans. J Gastroenterol. 2013;48:483\u201390.","journal-title":"J Gastroenterol"},{"key":"1587_CR5","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/jgh.12876","volume":"30","author":"T Kanno","year":"2015","unstructured":"Kanno T, Iijima K, Abe Y, et al. A multicenter prospective study on the prevalence of Helicobacter pylori-negative and nonsteroidal anti-inflammatory drugs-negative idiopathic peptic ulcers in Japan. J Gastroenterol Hepatol. 2015;30:842\u20138.","journal-title":"J Gastroenterol Hepatol"},{"key":"1587_CR6","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.cgh.2012.06.012","volume":"10","author":"GL Wong","year":"2012","unstructured":"Wong GL, Au KW, Lo AO, et al. Gastroprotective therapy does not improve outcomes of patients with Helicobacter pylori-negative idiopathic bleeding ulcers. Clin Gastroenterol Hepatol. 2012;10:1124\u20139.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1587_CR7","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/den.12635","volume":"28","author":"T Kanno","year":"2016","unstructured":"Kanno T, Iijima K, Abe Y, et al. Helicobacter pylori-negative and non-steroidal anti-inflammatory drugs-negative idiopathic peptic ulcers show refractoriness and high recurrence incidence: multicenter follow-up study of peptic ulcers in Japan. Dig Endosc. 2016;28:556\u201363.","journal-title":"Dig Endosc"},{"key":"1587_CR8","first-page":"1409","volume":"96","author":"P Bytzer","year":"2001","unstructured":"Bytzer P, Teglbjaerg PS, Danish Ulcer Study Group. Helicobacter pylori-negative duodenal ulcers: prevalence, clinical characteristics, and prognosis\u2014results from a randomized trial with 2-year follow-up. Am J Gastroenterol. 2001;96:1409\u201316.","journal-title":"Am J Gastroenterol"},{"key":"1587_CR9","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3904\/kjim.2015.30.5.559","volume":"30","author":"CS Chung","year":"2015","unstructured":"Chung CS, Chiang TH, Lee YC. A systematic approach for the diagnosis and treatment of idiopathic peptic ulcers. Korean J Intern Med. 2015;30:559\u201370.","journal-title":"Korean J Intern Med"},{"key":"1587_CR10","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/apt.13325","volume":"42","author":"Y Sakurai","year":"2015","unstructured":"Sakurai Y, Mori Y, Okamoto H, et al. Acid-inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects\u2014a randomised open-label cross-over study. Aliment Pharmacol Ther. 2015;42:719\u201330 PMID: 26193978.","journal-title":"Aliment Pharmacol Ther"},{"key":"1587_CR11","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/apt.13461","volume":"43","author":"K Ashida","year":"2016","unstructured":"Ashida K, Sakurai Y, Hori T, et al. Randomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis. Aliment Pharmacol Ther. 2016;43:240\u201351.","journal-title":"Aliment Pharmacol Ther"},{"key":"1587_CR12","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/apt.13876","volume":"45","author":"H Miwa","year":"2017","unstructured":"Miwa H, Uedo N, Watari J, et al. Randomised clinical trial: efficacy and safety of vonoprazan vs. lansoprazole in patients with gastric or duodenal ulcers\u2014results from two phase 3, non-inferiority randomised controlled trials. Aliment Pharmacol Ther. 2017;45:240\u201352.","journal-title":"Aliment Pharmacol Ther"},{"key":"1587_CR13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s00535-018-1487-6","volume":"54","author":"K Hamada","year":"2019","unstructured":"Hamada K, Uedo N, Tonai Y, et al. Efficacy of vonoprazan in prevention of bleeding from endoscopic submucosal dissection-induced gastric ulcers: a prospective randomized phase II study. J Gastroenterol. 2019;54:122\u201330.","journal-title":"J Gastroenterol"},{"key":"1587_CR14","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1159\/000456072","volume":"95","author":"S Hoshino","year":"2017","unstructured":"Hoshino S, Kawami N, Takenouchi N, et al. Efficacy of vonoprazan for proton pump inhibitor-resistant reflux esophagitis. Digestion. 2017;95:156\u201361.","journal-title":"Digestion"},{"key":"1587_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1055\/s-0028-1098086","volume":"3","author":"K Kimura","year":"1969","unstructured":"Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy. 1969;3:87\u201397.","journal-title":"Endoscopy"},{"key":"1587_CR16","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1053\/gast.2001.27999","volume":"121","author":"AM Ekstr\u00f6m","year":"2001","unstructured":"m AM, Held M, Hansson LE, et al. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology. 2001;121:784\u201391.","journal-title":"Gastroenterology"},{"key":"1587_CR17","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1034\/j.1600-0463.2003.1110604.x","volume":"111","author":"A Kokkola","year":"2003","unstructured":"Kokkola A, Kosunen TU, Puolakkainen P, et al. Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis. APMIS. 2003;111:619\u201324.","journal-title":"APMIS"},{"key":"1587_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1046\/j.1365-2036.2003.01402.x","volume":"17","author":"K Higuchi","year":"2003","unstructured":"Higuchi K, Fujiwara Y, Tominaga K, et al. Is eradication sufficient to heal gastric ulcers in patients infected with Helicobacter pylori? A randomized, controlled, prospective study. Aliment Pharmacol Ther. 2003;17:111\u20137.","journal-title":"Aliment Pharmacol Ther"},{"key":"1587_CR19","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1111\/apt.12465","volume":"38","author":"C Charpignon","year":"2013","unstructured":"Charpignon C, Lesgourgues B, Pariente A, et al. Peptic ulcer disease: one in five is related to neither Helicobacter pylori nor aspirin\/NSAID intake. Aliment Pharmacol Ther. 2013;38:946\u201354.","journal-title":"Aliment Pharmacol Ther"},{"key":"1587_CR20","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s10620-007-0028-6","volume":"53","author":"HJ Jang","year":"2008","unstructured":"Jang HJ, Choi MH, Shin WG, et al. Has peptic ulcer disease changed during the past 10 years in Korea? A prospective multi-center study. Dig Dis Sci. 2008;53:1527\u201331.","journal-title":"Dig Dis Sci"},{"key":"1587_CR21","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1111\/j.1440-1746.2009.06139.x","volume":"25","author":"TS Chen","year":"2010","unstructured":"Chen TS, Luo JC, Chang FY. Prevalence of Helicobacter pylori infection in duodenal ulcer and gastro-duodenal ulcer diseases in Taiwan. J Gastroenterol Hepatol. 2010;25:919\u201322.","journal-title":"J Gastroenterol Hepatol"},{"key":"1587_CR22","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00535-017-1412-4","volume":"53","author":"S Koizumi","year":"2018","unstructured":"Koizumi S, Motoyama S, Iijima K. Is the incidence of esophageal adenocarcinoma increasing in Japan? Trends from the data of a hospital-based registration system in Akita Prefecture. Japan. J Gastroenterol. 2018;53:827\u201333.","journal-title":"Japan. J Gastroenterol"},{"key":"1587_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1620\/tjem.246.131","volume":"246","author":"S Koizumi","year":"2018","unstructured":"Koizumi S, Motoyama S, Watanabe N, et al. Chronological changes in the gastric cancer subsite in Akita, Japan: the trends from the data of a hospital-based registration system. Tohoku J Exp Med. 2018;246:131\u201340.","journal-title":"Tohoku J Exp Med"},{"issue":"498\u2013506","key":"1587_CR24","first-page":"e1","volume":"13","author":"S Levenstein","year":"2015","unstructured":"Levenstein S, Rosenstock S, Jacobsen RK, et al. Psychological stress increases risk for peptic ulcer, regardless of Helicobacter pylori infection or use of nonsteroidal anti-inflammatory drugs. Clin Gastroenterol Hepatol. 2015;13(498\u2013506):e1.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1587_CR25","first-page":"120","volume":"5","author":"T Yamane","year":"2012","unstructured":"Yamane T, Ishii T, Umeda A, et al. Evaluation of six cases \nof idiopathic gastric antral ulcer. Gastroenterology Res. 2012;5:120\u20136.","journal-title":"Gastroenterology Res"},{"issue":"8719","key":"1587_CR26","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/0140-6736(90)92341-E","volume":"336","author":"S Levi","year":"1990","unstructured":"Levi S, Goodlad RA, Lee CY, et al. Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet. 1990;336(8719):840\u20133.","journal-title":"Lancet"},{"key":"1587_CR27","doi-asserted-by":"publisher","first-page":"43S","DOI":"10.1016\/S0002-9343(97)00211-8","volume":"104","author":"A Schmassmann","year":"1998","unstructured":"Schmassmann A. Mechanisms of ulcer healing and effects of nonsteroidal anti-inflammatory drugs. Am J Med. 1998;104:43S\u201351S (discussion 79S-80S. Review).","journal-title":"Am J Med"},{"key":"1587_CR28","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1111\/j.1572-0241.2002.05774.x","volume":"97","author":"DR Campbell","year":"2002","unstructured":"Campbell DR, Haber MM, Sheldon E, et al. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine. Am J Gastroenterol. 2002;97:2208\u201314.","journal-title":"Am J Gastroenterol"},{"key":"1587_CR29","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1136\/gut.51.3.344","volume":"51","author":"CJ Hawkey","year":"2002","unstructured":"Hawkey CJ, Wilson I, Naesdal J, et al. Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users. Gut. 2002;51:344\u201350.","journal-title":"Gut"},{"key":"1587_CR30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1136\/gut.39.1.22","volume":"39","author":"G Bianchi Porro","year":"1996","unstructured":"Bianchi Porro G, Parente F, Imbesi V, et al. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in long-term NSAID users. Response to omeprazole dual therapy. Gut. 1996;39:22\u20136.","journal-title":"Gut"},{"key":"1587_CR31","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/archinte.160.10.1455","volume":"160","author":"NM Agrawal","year":"2000","unstructured":"Agrawal NM, Campbell DR, Safdi MA, et al. Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group. Arch Intern Med. 2000;160:1455\u201361.","journal-title":"Arch Intern Med"},{"key":"1587_CR32","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1211\/0022357991773023","volume":"51","author":"M Sasakii","year":"1999","unstructured":"Sasakii M, Joh T, Yokoyama Y, et al. The therapeutic effect of proton pump inhibitors on Helicobacter pylori-positive gastric ulcers. J Pharm Pharmacol. 1999;51:825\u201330.","journal-title":"J Pharm Pharmacol"},{"key":"1587_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1056\/NEJM198901123200201","volume":"320","author":"A Walan","year":"1989","unstructured":"Walan A, Bader JP, Classen M, et al. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med. 1989;320:69\u201375.","journal-title":"N Engl J Med"},{"key":"1587_CR34","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1056\/NEJM199803123381104","volume":"338","author":"ND Yeomans","year":"1998","unstructured":"Yeomans ND, Tulassay Z, Juh\u00e1sz L, et al. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med. 1998;338:719\u201326.","journal-title":"N Engl J Med"},{"key":"1587_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1365-2036.1990.tb00445.x","volume":"4","author":"CW Howden","year":"1990","unstructured":"Howden CW, Hunt RH. The relationship between suppression of acidity and gastric ulcer healing rates. Aliment Pharmacol Ther. 1990;4:25\u201333.","journal-title":"Aliment Pharmacol Ther"},{"key":"1587_CR36","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1136\/gut.28.9.1120","volume":"28","author":"DB Jones","year":"1987","unstructured":"Jones DB, Howden CW, Burget DW, et al. Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs. Gut. 1987;28:1120\u20137.","journal-title":"Gut"},{"key":"1587_CR37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/gut.46.1.20","volume":"46","author":"K Iijima","year":"2000","unstructured":"Iijima K, Ohara S, Sekine H, et al. Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication. Gut. 2000;46:20\u20136.","journal-title":"Gut"},{"key":"1587_CR38","first-page":"1289","volume":"90","author":"DL Avner","year":"1995","unstructured":"Avner DL, Movva R, Nelson KJ, et al. Comparison of once daily doses of lansoprazole (15, 30, and 60 mg) and placebo in patients with gastric ulcer. Am J Gastroenterol. 1995;90:1289\u201394.","journal-title":"Am J Gastroenterol"},{"key":"1587_CR39","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1111\/j.1572-0241.2005.00243.x","volume":"100","author":"JL Goldstein","year":"2005","unstructured":"Goldstein JL, Johanson JF, Suchower LJ, et al. Healing of gastric ulcers with esomeprazole versus ranitidine in patients who continued to receive NSAID therapy: a randomized trial. Am J Gastroenterol. 2005;100:2650\u20137.","journal-title":"Am J Gastroenterol"},{"key":"1587_CR40","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/j.1365-2036.2007.03460.x","volume":"26","author":"JL Goldstein","year":"2007","unstructured":"Goldstein JL, Johanson JF, Hawkey CJ, et al. Clinical trial: healing of NSAID-associated gastric ulcers in patients continuing NSAID therapy\u2014a randomized study comparing ranitidine with esomeprazole. Aliment Pharmacol Ther. 2007;26:1101\u201311.","journal-title":"Aliment Pharmacol Ther"},{"key":"1587_CR41","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJM199803123381105","volume":"338","author":"CJ Hawkey","year":"1998","unstructured":"Hawkey CJ, Karrasch JA, Szczepa\u00f1ski L, et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. N Engl J Med. 1998;338:727\u201334.","journal-title":"N Engl J Med"},{"key":"1587_CR42","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/den.12764","volume":"29","author":"K Mizukami","year":"2017","unstructured":"Mizukami K, Murakami K. Effects of vonoprazan on intractable non-steroidal anti-inflammatory drug-induced ulcers that cannot be controlled with conventional proton pump inhibitors. Dig Endosc. 2017;29:233\u20134.","journal-title":"Dig Endosc"},{"key":"1587_CR43","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S0016-5085(19)33157-9","volume":"65","author":"JI Isenberg","year":"1973","unstructured":"Isenberg JI, Walsh JH, Grossman MI. Zollinger\u2013Ellison syndrome. Gastroenterology. 1973;65:140\u201365.","journal-title":"Gastroenterology"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-019-01587-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-019-01587-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-019-01587-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T23:23:16Z","timestamp":1588029796000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-019-01587-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,29]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["1587"],"URL":"https:\/\/doi.org\/10.1007\/s00535-019-01587-5","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,29]]},"assertion":[{"value":"26 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}